An intermediate in sterol biosynthesis
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Farnesyl Pyrophosphate (ammonium salt)

Item No. 63250

Technical Information
Formal Name
P-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl] ester-diphosphoric acid, triammonium salt
CAS Number
116057-57-9
Synonyms
  • FPP
Molecular Formula
C15H25O7P2 • 3NH4
Formula Weight
Purity
≥90%
Formulation
A 1 mg/ml solution in methanol:10 mM ammonium hydroxide (70:30)
Methanol:NH4OH (70:30): * 1 mg/ml
SMILES
C/C(C)=C/CC/C(C)=C/CC/C(C)=C/COP(OP([O-])([O-])=O)([O-])=O.[NH4+].[NH4+].[NH4+]
InChi Code
InChI=1S/C15H28O7P2.3H3N/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18;;;/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18);3*1H3/b14-9+,15-11+;;;
InChi Key
GSWRJNPTNZUHOV-VLCVYXDNSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Farnesyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway and used in the biosynthesis of terpenes, terpenoids, and sterols.1 It also serves as a donor in post-translational isoprenylation of proteins.2 FPP has been identified as an antagonist of P2Y12 receptors (IC50 = 45 μM), attenuating platelet aggregation.3 It has also been shown to regulate adipocyte function as an endogenous PPARγ agonist.4 Additionally, because of a flexible hydrocarbon chain that enables different conformations, FPP is a promiscuous ligand for a subset of nuclear receptors.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Vance, D.E. Cholesterol and related derivatives. Biochemistry 2nd ed., 725-748 (1988).

    2. McTaggart, S.J. Isoprenylated proteins. Cell Mol. Life Sci. 63(3), 255-267 (2006).

    3. Högberg, C., Gidlöf, O., Deflorian, F., et alFarnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation. Thromb. Haemost. 108(1), 119-132 (2012).

    4. Goto, T., Nagai, H., Egawa, K., et alFarnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. Biochem. J. 438(1), 111-119 (2011).

    5. Goyanka, R., Das, S., Samuels, H.H., et alNuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate. Protein Eng. Des. Sel. 23(11), 809-815 (2010).